bisphenol AWhat was measured
Measured, with no finding
443 endpoints
Show what was measuredHide what was measured
glucose and insulin tolerance tests
modulates
After 4 days of treatment with either E2 or BPA, these mice developed chronic hyperinsulinemia, and their glucose and insulin tolerance tests were altered
PMID 16393666 · one of two readings recorded this
glycemia after a single 10 ug/kg dose of BPA or E2 in adult mice; plasma insulin; islet insulin content; glucose and insulin tolerance tests
decreases, rapid decrease in glycemia
Not recorded as a finding: the paper never states the instrument the node requires
The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin.
PMID 16393666 · one of two readings recorded this
glycemia after a single 10 ug/kg dose, plasma insulin, pancreatic beta-cell insulin content, and glucose and insulin tolerance tests in adult mice
decreases, rapid decrease in glycemia correlating with a rise of plasma insulin
Not recorded as a finding: this platform holds no node for the endpoint
The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin.
PMID 16393666 · one of two readings recorded this
glycemia
decreases
The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin
PMID 16393666 · one of two readings recorded this
pancreatic beta-cell insulin content
increases
This effect is visible after 2 days of treatment and starting at doses as low as 10 microg/kg/day
PMID 16393666 · one of two readings recorded this
plasma insulin (chronic hyperinsulinemia)
increases
After 4 days of treatment with either E2 or BPA, these mice developed chronic hyperinsulinemia, and their glucose and insulin tolerance tests were altered
PMID 16393666 · one of two readings recorded this
plasma insulin
increases
The exposure of adult mice to a single low dose (10 microg/kg) of either E2 or BPA induces a rapid decrease in glycemia that correlates with a rise of plasma insulin
PMID 16393666 · one of two readings recorded this
DNA methylation patterns of multiple cell signaling genes
modulates
We found permanent alterations in the DNA methylation patterns of multiple cell signaling genes, suggesting an epigenetic basis for estrogen imprinting
PMID 16740699 · one of two readings recorded this
PDE4D4 5'-flanking CpG island methylation and expression with aging, normal prostate
decreases
a specific methylation cluster was identified in the 5'-flanking CpG island that was gradually hypermethylated with aging in normal prostates, resulting in loss of gene expression
PMID 16740699 · one of two readings recorded this
PDE4D4 gene methylation in prostate cancer cells
decreases
Cell line studies confirmed that site-specific methylation is involved in transcriptional silencing of the PDE4D4 gene and showed hypomethylation of this gene in prostate cancer cells
PMID 16740699 · one of two readings recorded this
PDE4D4 methylation and expression
increases
Early and prolonged hypomethylation at this site following neonatal estradiol or bisphenol A exposure resulted in continued, elevated PDE4D4 expression
PMID 16740699 · one of two readings recorded this
prostate susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis
increases
transient developmental exposure of rats to low, environmentally relevant doses of bisphenol A or estradiol increases prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis
PMID 16740699 · one of two readings recorded this
activated ERK1/2 levels
increases
we obtained increased levels of activated ERK1/2 15 minutes after treatment with the ERα agonist PPT
PMID 18446233 · one of two readings recorded this
E2 and BPA effects on islet insulin content with antiestrogen ICI182,780
decreases
Figures 4A and B show that ICI182,780 completely blocks both E2 and BPA effects in a dose dependent manner, indicating that estrogen receptors are involved
PMID 18446233 · one of two readings recorded this
E2- and BPA-induced increase in islet insulin content
decreases
Exposure to E2 or BPA strongly increased insulin content in islets from wild-type mice, yet this effect was completely abolished in islets from ERαKO mice
PMID 18446233 · one of two readings recorded this
E2- and BPA-induced increase in islet insulin content
increases
In contrast, a strong increase in insulin content was observed in E2 and BPA cultured islets from ERβKO mice
PMID 18446233 · one of two readings recorded this
ERK1/2 phosphorylation fluorescence intensity versus 0 min
increases, p = 0.01
*p = 0.01 Student's t-test comparing with column at 0 min
PMID 18446233 · one of two readings recorded this
glucose-induced insulin secretion
increases
islets incubated with 1 nM E2 for 48 hours secrete more insulin than those treated with vehicle
PMID 18446233 · one of two readings recorded this
increase in islet insulin content by PPT, BPA and E2 with ERK1/2 inhibitor PD98059
decreases
the increase in insulin content by the three ERα ligands was completely abolished by the ERK1/2 blocker PD98059
PMID 18446233 · one of two readings recorded this
increase in islet insulin content with c-Src inhibitor PP1
decreases
The c-Src inhibitor PP1 showed a tendency to also inhibit the effect of the ERα agonists in insulin content, although it is only statistically significant in the case of BPA
PMID 18446233 · one of two readings recorded this
insulin content of isolated mouse islets of Langerhans, radioimmunoassay (Coat-a-Count), after 48 h culture with BPA or after 4 days of BPA injection
increases
Not recorded as a finding: this platform holds no node for the endpoint
We then measured the insulin content of the islets isolated from BPA or vehicle-treated mice and found that the low dose of BPA increased insulin content while the high dose had no effect.
PMID 18446233 · one of two readings recorded this
insulin mRNA level
increases
insulin mRNA levels were induced 1.6 fold 6 hours after islets were exposed to 10nM E2
PMID 18446233 · one of two readings recorded this
intracellular calcium dynamics in response to glucose
no effect
None of the parameters analyzed showed significant differences
PMID 18446233 · one of two readings recorded this
islet area and BrdU incorporation
no effect
Islet area was unchanged in E2 vs. vehicle-treated islets and no increase on BrdU incorporation was observed
PMID 18446233 · one of two readings recorded this
islet area
no effect
Islet size was similar between islets from wild type and KO mice (12426±510 µm2 for ERαWT and 12123±415 µm2 for ERαKO; 15720±612 µm2 for ERβWT and 15977±764 µm2 for ERβKO; at least 100 islets from at least 3 different mice)
PMID 18446233 · one of two readings recorded this
islet area
no effect
Islet size was similar between islets from wild type and KO mice (12426±510 µm2 for ERαWT and 12123±415 µm2 for ERαKO; 15720±612 µm2 for ERβWT and 15977±764 µm2 for ERβKO; at least 100 islets from at least 3 different mice)
PMID 18446233 · one of two readings recorded this
islet cell viability
no effect
The islet cell viability remained high and similar in both E2 and vehicle-treated islets
PMID 18446233 · one of two readings recorded this
islet insulin content, dose response
increases
Insulin content increased following an inverted-U dose-dependent response at doses similar to the physiological concentrations of E2 observed in the mouse during pregnancy and in the proestrus stage
PMID 18446233 · one of two readings recorded this
islet insulin content, dose response
increases
Figure 3A shows a BPA-induced increase of insulin content following an inverted U-shape dose response curve, with a significant effect observed at 1 nM and 10 nM BPA when compared to vehicle exposed islets
PMID 18446233 · one of two readings recorded this
islet insulin content in vivo
no effect
We then measured the insulin content of the islets isolated from BPA or vehicle-treated mice and found that the low dose of BPA increased insulin content while the high dose had no effect
PMID 18446233 · one of two readings recorded this
islet insulin content in vivo
increases
We then measured the insulin content of the islets isolated from BPA or vehicle-treated mice and found that the low dose of BPA increased insulin content while the high dose had no effect
PMID 18446233 · one of two readings recorded this
islet insulin content
no effect
the ERβ agonist DPN produced no effect at any of the tested concentrations
PMID 18446233 · one of two readings recorded this
islet insulin content
increases
The ERα agonist PPT had the same effect on insulin content as E2
PMID 18446233 · one of two readings recorded this
islet insulin content
no effect
Higher concentrations of BPA as 1 µM produced no increase in insulin content
PMID 18446233 · one of two readings recorded this
non-stimulated islet insulin content
no effect
The absence of ERα or ERβ did not affect the non-stimulated insulin content of cultured islets when compared to wild-type mice
PMID 18446233 · one of two readings recorded this
pancreatic islet insulin content, radioimmunoassay (Coat-a-Count) after BPA in cultured mouse islets and in vivo
increases
Not recorded as a finding: this platform holds no node for the endpoint
Therefore BPA, like E2, increases pancreatic insulin content in a non-monotonic manner.
PMID 18446233 · one of two readings recorded this
FOS induction in GnRH neurons after hormone priming
decreases
FOS induction in hypothalamic gonadotropic (GnRH) neurons after hormone priming was impaired in the EB- and PPT-treated groups but neither of the BPA-treated groups
PMID 19535786 · one of two readings recorded this
ovarian antral-like follicles and corpora lutea
modulates
Severity of deficits within the BPA-treated groups increased with dose and included large antral-like follicles and lower numbers of corpora lutea
PMID 19535786 · one of two readings recorded this
ovarian morphology and folliculogenesis (EB)
decreases
Ovaries from the EB-treated females were undersized and showed no evidence of folliculogenesis
PMID 19535786 · one of two readings recorded this
ovarian morphology (PPT)
modulates
ovaries from the PPT-treated females were characterized by large antral-like follicles, which did not appear to support ovulation
PMID 19535786 · one of two readings recorded this
proportion of females acyclic
increases
A total of 67% of females exposed to the high BPA dose were acyclic by 15 wk after vaginal opening compared with 14% of those exposed to the low BPA dose
PMID 19535786 · one of two readings recorded this
proportion of females acyclic
increases
A total of 67% of females exposed to the high BPA dose were acyclic by 15 wk after vaginal opening compared with 14% of those exposed to the low BPA dose
PMID 19535786 · one of two readings recorded this
pubertal onset
decreases
Exposure to EB, PPT, or the low dose of BPA advanced pubertal onset
PMID 19535786 · one of two readings recorded this
sexual receptivity after ovariectomy and hormone replacement
no effect
Sexual receptivity, examined after ovariectomy and hormone replacement, was normal in all groups except those neonatally exposed to EB
PMID 19535786 · one of two readings recorded this
morphology of seminiferous cords, Sertoli cells, gonocytes, interstitial region and Leydig cells
no effect
Neither EE nor BPA exposure caused morphological changes in the developing seminiferous cords, Sertoli cells, gonocytes, or the interstitial region or Leydig cells at GD16-20
PMID 22752971 · one of two readings recorded this
StAR protein, interstitial region
no effect
Immunohistochemistry demonstrated similar StAR protein levels in interstitial region of GD16 testes
PMID 22752971 · one of two readings recorded this
StAR protein, interstitial region
decreases
an obvious decrease in StAR protein levels in the interstitial region of GD18 testes
PMID 22752971 · one of two readings recorded this
StAR protein, interstitial region
decreases
immunohistochemistry results demonstrated decreases in StAR protein levels in the interstitial region at the highest EE and BPA doses only
PMID 22752971 · one of two readings recorded this
StAR transcript levels
no effect
Quantitative reverse transcriptase PCR (QRT-PCR) demonstrated no significant difference in StAR transcript levels present at GD16
PMID 22752971 · one of two readings recorded this
StAR transcript levels
decreases
at GD18, StAR transcripts were significantly decreased following exposure
PMID 22752971 · one of two readings recorded this
StAR transcript levels
decreases
QRT-PCR validated previous microarray dose-related decreases in StAR transcripts at GD20
PMID 22752971 · one of two readings recorded this
StAR transcript (QRT-PCR) and StAR protein (immunohistochemistry) in fetal rat testis after transplacental BPA or ethynyl estradiol
decreases, decreased StAR protein in interstitial region at the highest EE and BPA doses only
Not recorded as a finding: this platform holds no node for the endpoint
QRT-PCR validated previous microarray dose-related decreases in StAR transcripts at GD20, whereas immunohistochemistry results demonstrated decreases in StAR protein levels in the interstitial region at the highest EE and BPA doses only.
PMID 22752971 · one of two readings recorded this
5-HIAA levels and 5-HIAA/5-HT
increases
BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice
PMID 23567477 · one of two readings recorded this
5-HIAA levels and 5-HIAA/5-HT
unclear
In contrast, alterations in those areas were much smaller in adult females and in both juvenile and adult males
PMID 23567477 · one of two readings recorded this
contextual fear conditioning memory, brain regional serotonin metabolite 5-HIAA and 5-HIAA/5-HT by HPLC, and Tph2, Slc6a4 and Maoa mRNA by quantitative real-time RT-PCR in mice
increases, enhanced fear memory and increased 5-HIAA levels in juvenile female mice
Not recorded as a finding: this platform holds no node for the endpoint
BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice.
PMID 23567477 · one of two readings recorded this
contextual fear memory and brain regional 5-HIAA and 5-HIAA/5-HT by HPLC in mice after perinatal BPA 250 ng/kg/day
increases, enhanced fear memory; increased 5-HIAA and 5-HIAA/5-HT in juvenile female brain regions
Not recorded as a finding: this platform holds no node for the endpoint
BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice.
PMID 23567477 · one of two readings recorded this
contextual fear memory
increases
BPA enhanced fear memory and increased serotonin metabolite (5-HIAA) levels and 5-HIAA/5-HT in the hippocampus, the striatum, the midbrain, the pons, and the medulla oblongata of juvenile female mice
PMID 23567477 · one of two readings recorded this
Tph2, Slc6a4 and Maoa mRNA expression
increases
BPA induced increases in the expression levels of Tph2, Slc6a4, and Maoa mRNA in the hippocampus of juvenile females
PMID 23567477 · one of two readings recorded this
DNA methylation of the ERα gene
modulates
Importantly, changes in ERα and DNMT expression in the cortex (males) and hypothalamus (females) were associated with DNA methylation changes in the ERα gene
PMID 23716699 · one of two readings recorded this
expression of estrogen receptor alpha, estrogen receptor beta and estrogen-related receptor-gamma genes
modulates
maternal exposure during pregnancy to environmentally relevant doses of BPA (2, 20, and 200 µg/kg/d) in mice induces sex-specific, dose-dependent (linear and curvilinear), and brain region-specific changes in expression of genes encoding estrogen receptors (ERs; ERα and ERβ) and estrogen-related receptor-γ in juvenile offspring
PMID 23716699 · one of two readings recorded this
mRNA levels of DNMT1 and DNMT3A
modulates
Concomitantly, BPA altered mRNA levels of epigenetic regulators DNA methyltransferase (DNMT) 1 and DNMT3A in the juvenile cortex and hypothalamus, paralleling changes in estrogen-related receptors
PMID 23716699 · one of two readings recorded this
postnatal maternal care
modulates
Although postnatal maternal care was altered in mothers treated with BPA during pregnancy, the effects of in utero BPA were not found to be mediated by maternal care
PMID 23716699 · one of two readings recorded this
social and anxiety-like behavior
modulates
BPA exposure induced persistent, largely sex-specific effects on social and anxiety-like behavior, leading to disruption of sexually dimorphic behaviors
PMID 23716699 · one of two readings recorded this
activity in open field test, sex difference
modulates
The OFT indicated that females were more active than males, and that BPA selectively increased rearing duration in males, thereby eliminating the gender effect
PMID 23824010 · one of two readings recorded this
anxiety-like action
decreases
The results of EPM showed that BPA did not enhance the anxiety-like action; rather, it was associated with an anxiolytic-like action in females
PMID 23824010 · one of two readings recorded this
immobility time and latency in the forced swimming test in rat offspring after lactational BPA; open field rearing; elevated plus maze
increases, increase in immobility time and reduced latency in BPA rats
Not recorded as a finding: this platform holds no node for the endpoint
In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats.
PMID 23824010 · one of two readings recorded this
immobility time
increases
In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats
PMID 23824010 · one of two readings recorded this
latency
decreases
In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats
PMID 23824010 · one of two readings recorded this
open field rearing duration, elevated plus maze anxiety-like behaviour, and forced swim test immobility time and latency in rat offspring exposed through lactation
increases, increase in immobility time and reduced latency in BPA rats
Not recorded as a finding: this platform holds no node for the endpoint
In the FST, not only there was an increase in the immobility time, but also there was reduction of latency observed in BPA rats.
PMID 23824010 · one of two readings recorded this
rearing duration
increases
BPA selectively increased rearing duration in males
PMID 23824010 · one of two readings recorded this
serum adiponectin
decreases
Compared to negative controls, males in the BPA-5, BPA-50 and BPA-5000 groups had significantly lower serum adiponectin, with maximal reduction in the BPA-50 group
PMID 23892310 · one of two readings recorded this
serum leptin
increases
The BPA-500 and the DES-0.1 groups had significantly elevated serum leptin levels compared to the negative controls and BPA-50,000 males
PMID 23892310 · one of two readings recorded this
body weight, all groups pooled, birth to postnatal day 22
increases
body weight increased significantly from an average of 1.73 g on the day of birth to 13.6 g on postnatal day 22 (week 3)
PMID 23892310 · one of two readings recorded this
body weight at weaning, quadratic vs linear model fit
modulates, p = 0.016
the quadratic model fit the data significantly better (P=0.016) than the linear-only model
PMID 23892310 · one of two readings recorded this
body weight at weaning
decreases
At weaning the BPA-5000 group had significantly decreased body weight compared to negative controls and DES-0.1 males (Table 1)
PMID 23892310 · one of two readings recorded this
body weight at week 19, quadratic vs linear model fit
modulates, p = 0.034
At week 19 (the end of the experiment) the regression analysis resulted in a significant difference between the groups as well as a better fit (P=0.034) relative to the linear-only model
PMID 23892310 · one of two readings recorded this
body weight at week 19
no effect, p = 0.07
The BPA-500 males tended to be heavier than negative controls (P=0.07) and were significantly heavier than BPA-5000 males (Table 1)
PMID 23892310 · one of two readings recorded this
body weight gain per week, weeks 15 to 19
increases
only the BPA-500 group showed a greater weight gain (2.82 ± 0.29 g) relative to negative controls (1.60 ± 0.18g) during this time
PMID 23892310 · one of two readings recorded this
body weight on day of birth
no effect, p = 0.08
although the BPA-500 males tended (P=0.08) to be heavier than negative controls
PMID 23892310 · one of two readings recorded this
glucose tolerance test AUC, linear ANOVA
no effect, p = 0.06
showed a tendency to be different (P = 0.06; Fig. 5A)
PMID 23892310 · one of two readings recorded this
glucose tolerance test AUC, quadratic vs linear model fit
modulates, p = 0.008
Addition of the quadratic term fit the data significantly better than the linear-only model (P = 0.008)
PMID 23892310 · one of two readings recorded this
glucose tolerance test AUC
increases
Compared to the negative controls, with the exception of the BPA-50,000 group, all other BPA dose groups as well as the DES-0.1 group showed significantly increased AUC values (impaired glucose tolerance)
PMID 23892310 · one of two readings recorded this
gonadal adipocyte number
increases
The BPA-5 and BPA-500 males had significantly more adipocytes compared to negative controls, the BPA-50, and BPA-50,000 males
PMID 23892310 · one of two readings recorded this
gonadal adipocyte number
increases
The DES-0.1 males also had significantly more adipocytes than negative controls, BPA-50 and BPA-50,000 males
PMID 23892310 · one of two readings recorded this
gonadal adipocyte volume
increases
Although no group had significantly different adipocyte volume relative to negative controls, BPA-5 and BPA-500 males had significantly larger adipocytes relative to BPA-50, BPA-50,000 and DES-0.1 males
PMID 23892310 · one of two readings recorded this
gonadal fat cell number
modulates, p = 0.002
The linear ANOVA for gonadal fat cell number was statistically significant (P<0.01), and addition of the quadratic term resulted in a significantly better fit than the linear-only model (P=0.002)
PMID 23892310 · one of two readings recorded this
gonadal fat cell volume, quadratic vs linear model fit
no effect, p = 0.052
addition of the quadratic term tended to result in a better fit relative to the linear-only model (P=0.052)
PMID 23892310 · one of two readings recorded this
gonadal fat pad weight, quadratic vs linear model fit
modulates, p = 0.022
addition of the quadratic term to the model provided a significantly better fit relative to the linear-only model (P=0.022; Table 2)
PMID 23892310 · one of two readings recorded this
gonadal fat pad weight
increases, p = 0.05
gonadal fat pad weight was significantly greater in the BPA-500 group (P<0.05)
PMID 23892310 · one of two readings recorded this
gonadal fat pad weight
increases, p = 0.01
the BPA-500 males also were significantly different compared to the BPA-50,000 group (P < 0.01; Fig. 2A)
PMID 23892310 · one of two readings recorded this
insulin tolerance test AUC, quadratic vs linear model fit
no effect, p = 0.137
adding the quadratic term to the model did not result in a statistically significant difference (P = 0.137)
PMID 23892310 · one of two readings recorded this
insulin tolerance test AUC
increases
the BPA-5 and BPA-5000 groups had significantly greater insulin insensitivity
PMID 23892310 · one of two readings recorded this
insulin tolerance test AUC
no effect, p = 0.07
the DES-0.1 males tended to have greater insulin insensitivity (P = 0.07)
PMID 23892310 · one of two readings recorded this
kidney weight
no effect
The linear ANOVA for kidney weight was not statistically significant, and addition of the quadratic term in the regression analysis also was also not statistically significant (data not shown)
PMID 23892310 · one of two readings recorded this
liver steatosis
no effect
there was no significant relationship between prenatal treatment and steatosis (data not shown)
PMID 23892310 · one of two readings recorded this
liver weight, quadratic vs linear model fit
modulates, p = 0.001
The linear ANOVA for liver weight was statistically significant (P = 0.01), and addition of the quadratic term in the regression analysis led to a significantly better fit compared to the linear-only model (P < 0.001)
PMID 23892310 · one of two readings recorded this
liver weight
increases, p = 0.01
Compared to the negative controls, the BPA-50 group had significantly higher liver weight (P < 0.01)
PMID 23892310 · one of two readings recorded this
metabolic energy intake, weeks 3 to 4, quadratic vs linear model fit
modulates, p = 0.028
between weeks 3 and 4 the quadratic model fit the data significantly better (P=0.028) than the linear-only model
PMID 23892310 · one of two readings recorded this
metabolic energy intake, weeks 3 to 4
increases, p = 0.05
the DES-0.1-treated animals exhibited the largest increase in metabolic energy intake relative to negative controls (P < 0.05)
PMID 23892310 · one of two readings recorded this
metabolic energy intake, weeks 4 to 5, quadratic vs linear model fit
modulates, p = 0.025
Between weeks 4 and 5 the quadratic model again fit the data better (P = 0.025) than the linear-only model
PMID 23892310 · one of two readings recorded this
metabolic energy intake, weeks 4 to 5
increases, p = 0.05
only the BPA-500 males exhibited a significant increase in metabolic energy intake relative to negative controls (P < 0.05)
PMID 23892310 · one of two readings recorded this
renal adipocyte number
increases
The BPA-500 males had significantly more adipocytes in the renal fat pad compared to the negative controls and all other BPA dose groups
PMID 23892310 · one of two readings recorded this
renal adipocyte volume
no effect, p = 0.06
Compared to the negative controls, the BPA-5 (P=0.06) and BPA-5000 (P< 0.01) had larger renal adipocytes
PMID 23892310 · one of two readings recorded this
renal adipocyte volume
increases, p = 0.01
Compared to the negative controls, the BPA-5 (P=0.06) and BPA-5000 (P< 0.01) had larger renal adipocytes
PMID 23892310 · one of two readings recorded this
renal fat pad weight, quadratic vs linear model fit
no effect, p = 0.076
addition of the quadratic term to the model tended to result in a better fit relative to the linear-only model (P=0.076)
PMID 23892310 · one of two readings recorded this
renal fat pad weight
increases
Compared to the negative controls and the BPA-50,000 groups, the BPA-500 group had elevated renal fat pad weight (P <0.05 and P <0.01, respectively)
PMID 23892310 · one of two readings recorded this
renal fat pad weight
no effect, p = 0.07
The DES-0.1 males tended (P=0.07) to have heavier renal fat pads compared to negative controls
PMID 23892310 · one of two readings recorded this
serum adiponectin, quadratic vs linear model fit
no effect, p = 0.099
addition of the quadratic term in the regression analysis tended to result in a better fit (P = 0.099) relative to the linear-only model
PMID 23892310 · one of two readings recorded this
serum insulin in fed animals, radioimmunoassay
increases, about 2-fold higher in the BPA-5 and DES-0.1 groups
Not recorded as a finding: no insulin concentration outcome node (only stimulated postprandial insulin exists, which requires an amino-acid preload and mixed drink)
The mean serum insulin level for the BPA-5 and DES-0.1 groups was significantly (about 2-fold) higher than the negative control and BPA-50,000 groups.
PMID 23892310 · one of two readings recorded this
serum insulin, mouse radioimmunoassay (fed state)
increases, about 2-fold higher in BPA-5 and DES-0.1 groups
Not recorded as a finding: No serum insulin outcome node; also compares against a BPA dose group and DES
The mean serum insulin level for the BPA-5 and DES-0.1 groups was significantly (about 2-fold) higher than the negative control and BPA-50,000 groups.
PMID 23892310 · one of two readings recorded this
serum insulin, quadratic vs linear model fit
modulates, p = 0.004
addition of the quadratic term in the regression analysis resulted in a significantly better fit relative to the linear-only model (P = 0.004)
PMID 23892310 · one of two readings recorded this
serum insulin
increases
The mean serum insulin level for the BPA-5 and DES-0.1 groups was significantly (about 2-fold) higher than the negative control and BPA-50,000 groups
PMID 23892310 · one of two readings recorded this
serum leptin, mouse radioimmunoassay (fed state)
increases, BPA-500 and DES-0.1 groups significantly elevated versus negative controls and BPA-50,000
Not recorded as a finding: Significant only in the BPA-500 stratum and the sentence also compares against another BPA dose group (BPA-50,000) and a DES positive control; no clean BPA-versus-vehicle contrast quotable in one sentence
The BPA-500 and the DES-0.1 groups had significantly elevated serum leptin levels compared to the negative controls and BPA-50,000 males.
PMID 23892310 · one of two readings recorded this
serum leptin, quadratic vs linear model fit
no effect, p = 0.349
addition of the quadratic term did not result in a significantly different fit relative to the linear-only model (P = 0.349)
PMID 23892310 · one of two readings recorded this
serum leptin versus total abdominal fat weight profile
increases, p = 0.001
The profile for the BPA dose effect on adult serum leptin matched the total abdominal fat weight profile (; Spearman correlation coefficient = 0.86; P < 0.001)
PMID 23892310 · one of two readings recorded this
total abdominal fat weight, quadratic vs linear model fit
modulates, p = 0.047
inclusion of the quadratic term resulted in a significantly better fit than the linear-only model (P=0.047)
PMID 23892310 · one of two readings recorded this
total abdominal fat weight
increases
Compared to the negative controls and the BPA-50,000 groups, the BPA-500 group had more total abdominal fat (P < 0.05 and P < 0.01, respectively)
PMID 23892310 · one of two readings recorded this
total metabolic energy consumed, weeks 15 to 19
modulates, p = 0.001
prenatal treatment was significantly different based on linear ANOVA for the total amount metabolic energy consumed over this 4-week period (P < 0.001)
PMID 23892310 · one of two readings recorded this
human oocyte meiotic maturation in vitro, percentage of germinal vesicle oocytes reaching metaphase II after 30 h culture with BPA at 20 and 200 ng/ml and 20 ug/ml versus sibling control without BPA; spindle configuration and chromosome alignment by immunofluorescence and confocal microscopy
decreases, p = 0.002
Not recorded as a finding: this platform holds no node for the endpoint
As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007).
PMID 23904465 · one of two readings recorded this
Incidence of aligned chromosomes among MII oocytes
decreases, p = 0.02
Among MII oocytes, as the BPA dose increased, there was a significant trend (by test for trend) for a decreased incidence of bipolar spindles (P < 0.0001) and aligned chromosomes (P = 0.02)
PMID 23904465 · one of two readings recorded this
Incidence of bipolar spindles among MII oocytes
decreases, p = 0.0001
Among MII oocytes, as the BPA dose increased, there was a significant trend (by test for trend) for a decreased incidence of bipolar spindles (P < 0.0001) and aligned chromosomes (P = 0.02)
PMID 23904465 · one of two readings recorded this
Percentage of degenerated oocytes
increases, p = 0.01
As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007)
PMID 23904465 · one of two readings recorded this
percentage of human GV-stage oocytes progressing to metaphase II after 30 h in vitro culture with BPA (20, 200 ng/ml, 20 ug/ml) versus sibling oocytes without BPA; also degeneration, spontaneous activation, bipolar spindle and chromosome alignment, by immunofluorescence and confocal microscopy
decreases, dose-dependent decrease in the percentage of oocytes progressing to MII, p = 0.002
Not recorded as a finding: this platform holds no node for the endpoint
As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007).
PMID 23904465 · one of two readings recorded this
Percentage of oocytes progressing to metaphase II (MII)
decreases, p = 0.002
As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007)
PMID 23904465 · one of two readings recorded this
Percentage of oocytes with spontaneous activation
increases, p = 0.007
As the BPA dose increased, there was a decrease in the percentage of oocytes that progressed to MII (P = 0.002) and increases in the percentage of oocytes that were degenerated (P = 0.01) or that had undergone spontaneous activation (P = 0.007)
PMID 23904465 · one of two readings recorded this
neuronal differentiation after withdrawal
decreases
The inhibitory effects were still observed when PC12 cells were treated with BPA or NP for a week, followed by a week's withdrawal
PMID 24746930 · one of two readings recorded this
neuronal differentiation of PC12 cells after pre-exposure to 0.1-100 nM BPA
decreases, decreased after one week or one month pre-exposure, not after one day
Not recorded as a finding: this platform holds no node for the endpoint
Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells.
PMID 24746930 · one of two readings recorded this
neuronal differentiation of pheochromocytoma PC12 cells after pre-exposure to 0.1-100 nM BPA
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells.
PMID 24746930 · one of two readings recorded this
neuronal differentiation
no effect
Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells
PMID 24746930 · one of two readings recorded this
neuronal differentiation
decreases
Pre-exposure to BPA for a week or a month, but not for a day, decreased neuronal differentiation in PC12 cells
PMID 24746930 · one of two readings recorded this
neuronal differentiation
decreases
Likewise, one week's pre-exposure to NP also inhibited neuronal differentiation in these cells
PMID 24746930 · one of two readings recorded this
hippocampal synaptic structure (synaptic cleft, PSD thickness, synaptic vesicles)
modulates
Maternal BPA exposure had an adverse effect on synaptic structure, including a widened synaptic cleft, a thinned postsynaptic density (PSD), unclear synaptic surface and disappeared synaptic vesicles
PMID 24820113 · one of two readings recorded this
locomotor activity, exploratory habits and emotional behavior
modulates
Maternal BPA exposure significantly affected locomotor activity, exploratory habits, and emotional behavior in open field test
PMID 24820113 · one of two readings recorded this
reference and working memory errors in the radial arm maze, open field behavior, hippocampal synaptic ultrastructure and synaptic protein expression in male rat offspring after maternal BPA
increases, increased reference and especially working memory errors
Not recorded as a finding: a node exists but the paper states a different instrument or population
Maternal BPA exposure significantly affected locomotor activity, exploratory habits, and emotional behavior in open field test, and increased reference and especially working memory errors in the radial arm maze during the postnatal developing stage.
PMID 24820113 · one of two readings recorded this
reference and working memory errors in the radial arm maze, open field behaviour, hippocampal synaptic ultrastructure and synaptic protein mRNA and protein expression in male rat offspring at PND 21
increases, increased reference and especially working memory errors in the radial arm maze
Not recorded as a finding: a node exists but the paper states a different instrument or population
Maternal BPA exposure significantly affected locomotor activity, exploratory habits, and emotional behavior in open field test, and increased reference and especially working memory errors in the radial arm maze during the postnatal developing stage.
PMID 24820113 · one of two readings recorded this
reference and working memory errors
increases
increased reference and especially working memory errors in the radial arm maze during the postnatal developing stage
PMID 24820113 · one of two readings recorded this
synaptophysin, PSD-95, spinophilin, GluR1 and NMDAR1 mRNA and protein expression
decreases
maternal BPA exposure decreased the mRNA and protein expressions of synaptophysin, PSD-95, spinophilin, GluR1 and NMDAR1 in the hippocampus of male offspring on PND 21
PMID 24820113 · one of two readings recorded this
ATP1A2 expression in microarray meta-analysis (log2 fold change)
increases, p = 0.00000613
UNC5B | unc-5 Homolog B | −1.4892 | 3.45E–06 | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 0.9995 | 6.13E–06
PMID 25051057 · one of two readings recorded this
ESR1 expression in microarray meta-analysis (log2 fold change)
increases, p = 0.00000274
PAX6 | paired box 6 | −1.9937 | 1.05E–08 | ESR1 | estrogen receptor 1 | 1.1477 | 2.74E–06
PMID 25051057 · one of two readings recorded this
Number of differentially expressed genes
(1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)
PMID 25051057 · one of two readings recorded this
Number of differentially expressed genes
(1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)
PMID 25051057 · one of two readings recorded this
Number of differentially expressed genes
(1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)
PMID 25051057 · one of two readings recorded this
Number of differentially expressed genes
(1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)
PMID 25051057 · one of two readings recorded this
Number of differentially expressed genes
(1 pM n = 25, 100 pM n = 109, 10 nM n = 145, 1 uM n = 250, 10 uM n = 345)
PMID 25051057 · one of two readings recorded this
Pax6 expression in cord blood, high vs low BPA group (fold change)
decreases
Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively)
PMID 25051057 · one of two readings recorded this
PAX6 expression in microarray meta-analysis (log2 fold change)
decreases, p = 1.05e-8
PAX6 | paired box 6 | −1.9937 | 1.05E–08 | ESR1 | estrogen receptor 1 | 1.1477 | 2.74E–06
PMID 25051057 · one of two readings recorded this
Sox2 and Pax6 mRNA expression in human umbilical cord blood by real-time PCR, high vs low cord-blood BPA group (median 16.8 nM, n = 20); plus meta-analysis of three public microarray datasets of human cell models
decreases, fold change 0.1 (Sox2) and 0.08 (Pax6), high vs low BPA group, n = 20
Not recorded as a finding: this platform holds no node for the endpoint
Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively).
PMID 25051057 · one of two readings recorded this
Sox2 and Pax6 mRNA expression in human umbilical cord blood, high vs low BPA group (median 16.8 nM), real-time PCR; plus microarray meta-analysis of differentially expressed genes in human cell models exposed to BPA
decreases, fold change 0.1 (Sox2) and 0.08 (Pax6), high vs low BPA group
Not recorded as a finding: this platform holds no node for the endpoint
Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively).
PMID 25051057 · one of two readings recorded this
Sox2 expression in cord blood, high vs low BPA group (fold change)
decreases
Both gene expression of Sox2 and Pax6 significantly decreased in higher BPA group referred to lower BPA group (fold change 0.1 and 0.08, respectively)
PMID 25051057 · one of two readings recorded this
SOX2 expression in microarray meta-analysis (log2 fold change)
decreases, p = 3.22e-10
SOX2 | SRY (Sex Determining Region Y)-Box 2 | −1.20 | 3.22E–10 | TGFB2 | transforming growth factor, beta 2 | 0.9657 | 5.07E–07
PMID 25051057 · one of two readings recorded this
TGFB2 expression in microarray meta-analysis (log2 fold change)
increases, p = 5.07e-7
SOX2 | SRY (Sex Determining Region Y)-Box 2 | −1.20 | 3.22E–10 | TGFB2 | transforming growth factor, beta 2 | 0.9657 | 5.07E–07
PMID 25051057 · one of two readings recorded this
UNC5B expression in microarray meta-analysis (log2 fold change)
decreases, p = 0.00000345
UNC5B | unc-5 Homolog B | −1.4892 | 3.45E–06 | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 0.9995 | 6.13E–06
PMID 25051057 · one of two readings recorded this
glycaemia, glucose tolerance and cholesterolemia
increases
We report a specific impact of BPA exposure on glycaemia, glucose tolerance and cholesterolemia
PMID 25168180 · one of two readings recorded this
hepatic mRNA of cholesterol biosynthesis genes Mvd, Lss, Hmgcr and Sqle
increases
RT-qPCR performed on hepatic mRNA from same animals demonstrated an overexpression of key genes involved in cholesterol biosynthesis, namely, Mvd, Lss Hmgcr, and Sqle
PMID 25168180 · one of two readings recorded this
plasma lathosterol to cholesterol ratio (whole body cholesterol de novo synthesis)
increases
As shown by the plasma lathosterol to cholesterol ratio, a surrogate marker for cholesterol biosynthesis, whole body cholesterol de novo synthesis was also increased in BPA-exposed animals
PMID 25168180 · one of two readings recorded this
sterol regulatory element-binding protein 2 expression
increases
BPA also induced the expression of the sterol regulatory element-binding proteins 2, a master regulator of hepatic cholesterol biosynthesis
PMID 25168180 · one of two readings recorded this
Abnormal glucose (FPG >=100 mg/dL) in children, adjusted OR
no effect
Q3: 2.6–4.9 | Q4 vs. Q1: OR = 0.63 (0.22–1.82)
PMID 26026606 · one of two readings recorded this
BMI, correlation with BPA
increases, p = 0.001
BMI: r = 0.298 (p < 0.001)
PMID 26026606 · one of two readings recorded this
Body weight, adjusted beta
increases
Weight: β = 0.0064 (0.0023–0.0104)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
no effect
Q4 vs. Q1: OR = 1.71 (0.89–3.26)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
Q4 vs. Q1: OR = 1.37 (1.08–1.74)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
Q4 vs. Q1: OR = 1.68 (1.22–2.30)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
no effect
Pooled 2003/08: OR = 1.065 (0.973–1.166)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
OR = 1.39 (1.21–1.60)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
Pooled 2003/06: OR = 1.24 (1.10–1.40)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
Pooled 2003/08: OR = 1.08 (1.02–1.16)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
Q4 vs. Q1: OR = 3.17 (1.23–8.18)
PMID 26026606 · one of two readings recorded this
Diabetes, adjusted OR
increases
Q4 vs. Q1: OR = 1.56 (1.09–2.24)
PMID 26026606 · one of two readings recorded this
Elevated waist circumference, adjusted OR
increases
Q4 vs. Q1: OR = 1.59 (1.21–2.09)
PMID 26026606 · one of two readings recorded this
Elevated waist circumference, adjusted OR
increases
Q4 vs. Q1: OR = 1.28 (1.03–1.60)
PMID 26026606 · one of two readings recorded this
Fat mass, correlation with BPA
increases, p = 0.001
Fat mass: r = 0.35 (p < 0.001)
PMID 26026606 · one of two readings recorded this
High blood pressure, adjusted OR
no effect
Weighted model (additionally adjusted for subsample weighting): OR = 1.12 (0.93–1.35)
PMID 26026606 · one of two readings recorded this
Hyperglycemia (FPG >=100 mg/dL), adjusted OR
no effect
Q4 vs. Q1: OR = 1.1 (0.6–1.9)
PMID 26026606 · one of two readings recorded this
Incident CAD, adjusted OR
increases
OR = 1.11 (1.00–1.23)
PMID 26026606 · one of two readings recorded this
Incident diabetes, adjusted OR
no effect
no significant results were found in older women from the NHS study (OR = 0.81, 95 % CI: 0.48–1.38, for Q4 vs. Q1)
PMID 26026606 · one of two readings recorded this
Incident diabetes, adjusted OR
increases
a positive association between uBPA and incident diabetes was reported among middle-aged women from the NHSII study (OR = 2.08, 95 % CI: 1.17–3.69, for Q4 vs. Q1)
PMID 26026606 · one of two readings recorded this
Prediabetes, adjusted OR
increases
T3 vs. T1: OR = 1.34 (1.03–1.73)
PMID 26026606 · one of two readings recorded this
Prediabetes, adjusted OR
increases
T3 vs. T1: OR = 1.65 (1.04–2.80)
PMID 26026606 · one of two readings recorded this
Prediabetes, adjusted OR
increases
T3 vs. T1: OR = 1.49 (1.00–2.22)
PMID 26026606 · one of two readings recorded this
Prevalent BMI as continuous, adjusted beta
increases
Wang et al. 2012b | Prevalent BMI as continuous (kg/m2) | BPA continuous (log-transformed and corrected for specific gravity) | β = 0.017 (0.002–0.032) | Age, sex
PMID 26026606 · one of two readings recorded this
Prevalent diabetes, pooled OR by uBPA quartile
increases
Pooled ORs (95 % CI) were 1.33 (1.10–1.61), 1.18 (0.97–1.44) and 1.47 (1.21–1.80) in the second, third, and fourth uBPA quartiles compared to the first uBPA quartile
PMID 26026606 · one of two readings recorded this
Prevalent diabetes, pooled OR by uBPA quartile
no effect
Pooled ORs (95 % CI) were 1.33 (1.10–1.61), 1.18 (0.97–1.44) and 1.47 (1.21–1.80) in the second, third, and fourth uBPA quartiles compared to the first uBPA quartile
PMID 26026606 · one of two readings recorded this
Prevalent diabetes, pooled OR highest vs lowest uBPA
increases
Prevalent diabetes | 3 | 1.47 (1.21–1.80) | 0.55 | 0
PMID 26026606 · one of two readings recorded this
Prevalent elevated waist circumference, pooled OR highest vs lowest uBPA
increases
Total | 4 | 1.48 (1.25–1.76) | 0.28 | 21
PMID 26026606 · one of two readings recorded this
Prevalent elevated waist circumference, pooled OR highest vs lowest uBPA
increases
Adults only | 3 | 1.52 (1.21–1.90) | 0.15 | 47
PMID 26026606 · one of two readings recorded this
Prevalent hypertension, adjusted OR
no effect
Q4 vs. Q1: OR = 1.27 (0.85–1.88)
PMID 26026606 · one of two readings recorded this
Prevalent hypertension, adjusted OR
increases
T3 vs. T1: OR = 1.50 (1.12–2.00)
PMID 26026606 · one of two readings recorded this
Prevalent hypertension, adjusted OR
increases
Q4 vs. Q1: OR = 2.35 (1.33–4.17)
PMID 26026606 · one of two readings recorded this
Prevalent hypertension, pooled OR highest vs lowest uBPA
increases
Prevalent hypertension | 2 | 1.41 (1.12–1.79) | 0.50 | 0
PMID 26026606 · one of two readings recorded this
Prevalent obesity, adjusted OR
increases
Q4 vs. Q1: OR = 2.55 (1.65–3.95)
PMID 26026606 · one of two readings recorded this
Prevalent obesity, adjusted OR
increases
Q4 vs. Q1: OR = 1.76 (1.06–2.94)
PMID 26026606 · one of two readings recorded this
Prevalent obesity, adjusted OR
increases
Q4 vs. Q1: OR = 2.05 (1.38–3.04)
PMID 26026606 · one of two readings recorded this
Prevalent obesity, adjusted OR
increases
Q4 vs. Q1: OR = 1.69 (1.30–2.20)
PMID 26026606 · one of two readings recorded this
Prevalent obesity, adjusted OR
increases
Q4 vs. Q1: OR = 2.57 (1.72–3.83)
PMID 26026606 · one of two readings recorded this
Prevalent obesity, adjusted OR
increases
Q4 vs. Q1: OR = 1.50 (1.15–1.97)
PMID 26026606 · one of two readings recorded this
prevalent obesity and elevated waist circumference by urinary BPA, pooled OR highest vs lowest category of cross-sectional studies; also prevalent diabetes, overweight and hypertension pooled ORs
increases
Not recorded as a finding: this platform holds no node for the endpoint
Higher BPA exposure was significantly associated with obesity and elevated WC, and no significant heterogeneity between studies was found (Table 5).
PMID 26026606 · one of two readings recorded this
prevalent obesity, elevated waist circumference, overweight, hypertension and prevalent diabetes; pooled OR of highest vs lowest urinary BPA category from cross-sectional studies, random effects (obesity pooled OR 1.67, 95% CI 1.41-1.98 in Table 5)
increases
Not recorded as a finding: this platform holds no node for the endpoint
Higher BPA exposure was significantly associated with obesity and elevated WC, and no significant heterogeneity between studies was found (Table 5).
PMID 26026606 · one of two readings recorded this
Prevalent obesity, pooled OR highest vs lowest uBPA
increases
Total | 3 | 1.67 (1.41–1.98) | 0.44 | 0
PMID 26026606 · one of two readings recorded this
Prevalent obesity, pooled OR highest vs lowest uBPA
increases
Adults only | 2 | 1.60 (1.32–1.93) | 0.54 | 0
PMID 26026606 · one of two readings recorded this
Prevalent overweight, adjusted OR
no effect
Q4 vs. Q1: OR = 1.31 (0.80–2.14)
PMID 26026606 · one of two readings recorded this